Holen Sie sich die Stockscreener-App
0.9811
1.64%
-0.0164
Handel nachbörslich:
.99
0.0089
+0.91%
Schlusskurs vom Vortag:
$0.9975
Offen:
$1.02
24-Stunden-Volumen:
832.96K
Relative Volume:
0.73
Marktkapitalisierung:
$106.15M
Einnahmen:
$4.35M
Nettoeinkommen (Verlust:
$-45.53M
KGV:
-0.9084
EPS:
-1.08
Netto-Cashflow:
$-44.79M
1W Leistung:
-0.89%
1M Leistung:
-13.94%
6M Leistung:
-27.86%
1J Leistung:
+14.08%
1-Tages-Spanne:
$0.965
$1.0295
1-Wochen-Bereich:
$0.9502
$1.03
52-Wochen-Spanne:
$0.73
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Firmenname
Lucid Diagnostics Inc
Sektor
Branche
Telefon
212 949 4319
Adresse
360 MADISON AVENUE, NEW YORK
Vergleichen Sie LUCD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
0.9811 | 107.96M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2021-11-08 | Eingeleitet | BTIG Research | Buy |
| 2021-11-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-11-08 | Eingeleitet | Needham | Buy |
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
Transcript : PAVmed Inc., Lucid Diagnostics Inc., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener
Earnings call transcript: Lucid Diagnostics highlights Q2 2025 growth and Medicare focus - Investing.com
Lucid Diagnostics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Lucid Diagnostics Inc: Navigating Earnings Challenges and Strategic Growth in a Competitive Diagnostics Landscape - AInvest
Lucid Diagnostics Advances Towards Medicare Coverage - TipRanks
Lucid Diagnostics earnings beat, revenue was in line with estimates By Investing.com - Investing.com Canada
Lucid Diagnostics Inc Q2 loss per share $0.08 - MarketScreener
LUCD Reports Results - Nasdaq
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results - PR Newswire
Lucid Diagnostics 2025 Q2 Earnings Losses Narrow as Net Income Improves 59.7% - AInvest
Lucid Diagnostics Inc. SEC 10-Q Report - TradingView
PAVmed's Q2 2025 Earnings: A Strategic Inflection Point in Healthcare Innovation and Financial Turnaround - AInvest
What To Expect From Lucid Diagnostics Inc (LUCD) Q2 2025 Earnings - Yahoo Finance
Lucid Diagnostics LUCD 2025Q2 Earnings Preview Downside Anticipated on Underwhelming Market Performance - AInvest
Why Lucid Diagnostics Inc. stock attracts strong analyst attentionDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Lucid Diagnostics to Participate in Upcoming Investor Conferences - Eastern Progress
Lucid Diagnostics Inc. Breakout Confirmed by Volume MetricsROI Boosting Trade Opportunity Calendar Published - beatles.ru
What institutional investors are buying Lucid Diagnostics Inc. stockFree Trading Strategy Suggestions - Jammu Links News
Does Lucid Diagnostics Inc. stock perform well during market downturnsInvest confidently with actionable market data - Jammu Links News
How strong is Lucid Diagnostics Inc. company’s balance sheetConsistent triple-digit returns - Jammu Links News
What are the technical indicators suggesting about Lucid Diagnostics Inc.Achieve consistent profits with expert advice - Jammu Links News
When is Lucid Diagnostics Inc. stock expected to show significant growthUnlock your portfolio’s full growth potential - Jammu Links News
Is Lucid Diagnostics Inc. a good long term investmentFree Stock Chart Pattern Guide - Jammu Links News
Should I hold or sell Lucid Diagnostics Inc. stock in 2025Outstanding capital growth - Jammu Links News
What are Lucid Diagnostics Inc. company’s key revenue driversRapid capital growth - Jammu Links News
Published on: 2025-08-03 06:14:38 - Jammu Links News
How does Lucid Diagnostics Inc. generate profit in a changing economyMaximize returns with smart investment plans - Jammu Links News
PAVmed gets 180-day extension to regain Nasdaq listing compliance - MSN
PAVmed CEO and CFO to Present Q2 2025 Results and Growth Strategy Update on August 14 - Stock Titan
Lucid Diagnostics to Host Business Update Conference Call and Webcast on August 13, 2025 - AInvest
Lucid Diagnostics Announces Business Update Conference Call on August 13, 2025 - AInvest
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - WV News
Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG - MSN
Cancer Prevention Leader Lucid Diagnostics to Reveal Q2 2025 Financial Results and Growth Strategy - Stock Titan
What drove LUCD's surprise Q3 earnings beat? - AInvest
What explains LUCD's volatile earnings in 2024? - AInvest
Lucid Diagnostics Awaits Medicare Coverage for EsoGuard Test: Analysts Project 245.48% Price Appreciation and 333.71% Upside Potential - AInvest
Lucid Diagnostics on Track for Medicare Coverage Boosts BTIG's Buy Rating to $2 Target - AInvest
Why did LUCD's Q4 earnings fall short of forecasts? - AInvest
How does Lucid Diagnostics Inc. compare to its industry peersStock Strategy Picks For 2025 - jammulinksnews.com
Lucid Diagnostics' Medicare Coverage Catalyst: A Strategic Inflection Point for Esophageal Cancer Prevention - AInvest
How many analysts rate Lucid Diagnostics Inc. as a “Buy”Achieve consistent profits with expert strategies - Jammu Links News
What is Lucid Diagnostics Inc. company’s growth strategyAchieve consistent profits with proven methods - Jammu Links News
Is Lucid Diagnostics Inc. a growth stock or a value stockInvest confidently with professional market insights - Jammu Links News
What are the latest earnings results for Lucid Diagnostics Inc.Extraordinary market timing - jammulinksnews.com
Lucid Diagnostics Inc. Earnings Report Breakdown: What Investors Should KnowFree Stock Market Insider Analysis - Newser
What is the dividend policy of Lucid Diagnostics Inc. stockDiscover the next big stock winners - Jammu Links News
Sectors Driving Future Growth for Lucid Diagnostics Inc. StockDaily Price Surge List - Newser
Finanzdaten der Lucid Diagnostics Inc-Aktie (LUCD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lucid Diagnostics Inc-Aktie (LUCD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Matheis Dennis | Director |
May 21 '25 |
Buy |
1.32 |
129,684 |
171,520 |
316,782 |
| Matheis Dennis | Director |
May 22 '25 |
Buy |
1.32 |
33,218 |
43,795 |
350,000 |
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):